Qube Research & Technologies (QRT)
TELO icon

Qube Research & Technologies (QRT)’s Telomir Pharmaceuticals TELO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
+21,792
New +$28.4K ﹤0.01% 3191
2025
Q4 		– Sell
-11,015
Closed -$15.3K – 4159
2025
Q3 		$15.3K Sell
11,015
-15,494
-58% -$23.4K ﹤0.01% 3314
2025
Q2 		$33.1K Buy
+26,509
New +$61.3K ﹤0.01% 3205

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TELO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Telomir Pharmaceuticals (TELO) in Q2 2026: 21,792 shares worth $27.9K. The stake represents ﹤0.01% of the portfolio and ranks #3191 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in TELO as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in TELO in Q2 2025 and has held it in 3 quarters since. The position peaked at $33.1K in Q2 2025. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 21,792 shares of Telomir Pharmaceuticals worth $27.9K as of Q2 2026.
  • Telomir Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3191 holding.
  • Qube Research & Technologies (QRT) first reported a position in Telomir Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Telomir Pharmaceuticals position peaked at $33.1K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.